Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-15 5:02 pm Purchase |
2023-05-08 | 13G | Soleno Therapeutics, Inc. SLNO |
Vivo Opportunity Fund Holdings, L.P. | 8,418,093 19.990% |
8,418,093 (New Position) |
Filing |